CSIMarket
 
T2 Biosystems Inc   (TTOO)
Other Ticker:  
 
 

T2 Biosystems Inc's Customers Performance

TTOO

 
TTOO's Source of Revenues During the corresponding time, T2 Biosystems Inc revenue deteriorated by -59.97 % year on year, sequentially revenue fell by -25.05 %. While revenue at the T2 Biosystems Inc 's corporate clients

List of TTOO Customers




for the same period T2 Biosystems Inc revnue deteriorated by -59.97 % year on year, sequentially revnue fell by -25.05 %.

List of TTOO Customers




T2 Biosystems Inc's Comment on Sales, Marketing and Customers





  News about T2 Biosystems Inc Contracts

Advancements in T2Resistance Panel Enable Faster Targeted Therapy for Drug-Resistant Infections

T2 Biosystems, a leading diagnostics company, has recently published a study highlighting the clinical benefits and performance of their groundbreaking T2Resistance Panel. This study has demonstrated that the utilization of T2Resistance Panel enables faster targeted therapy, providing a significant advantage in the battle against drug-resistant infections.The T2Resistance Panel is an innovative diagnostic tool that detects resistance genes directly from a patient's blood sample. This breakthrough technology eliminates the need for time-consuming and expensive culture-based methods, delivering results in a matter of hours rather than days. By swiftly identifying specific resistance genes, healthcare professio...

T2 Biosystems Joins Forces with NIH in Groundbreaking Study to Revolutionize Pneumonia Diagnosis

T2 Biosystems Joins NIH-funded Pilot Study to Revolutionize Pneumonia Detection through Innovative Diagnostic ApproachesLEXINGTON, Mass., Jan. 18, 2024 - T2 Biosystems, Inc. (NASDAQ: TTOO), a prominent leader in rapid detection technology for sepsis-causing pathogens and antibiotic resistance genes, has recently announced its participation in the Antibacterial Resistance Leadership Group (ARLG) pilot study funded by the National Institutes of Health (NIH). The study, known as the Pneumonia Direct Pilot, aims to explore new diagnostic approaches for ventilator-associated pneumonia (VAP) while also detecting antibiotic-resistant infections more comprehensively.Under the guidance of the renowned Dr. Kimberly Ha...












TTOO's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
T2 Biosystems Inc 18.72 11.00 -49.84 -
SUBTOTAL 0.00 0.00 0.00 -


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com